BLOG POST
New survey findings reveal that while medication initiation and persistence is a top commercial objective, most brands are still missing the post-prescription engagement opportunity.
Helping patients stay on treatment is a core commercial objective for brand teams, but is your channel mix keeping up? In our January–February 2026 survey of pharma marketers, the need for support to help patients start and stay on therapy was clear. There’s an opportunity to help close that gap with Post-Script Engagement (PSE).
Despite this, most media plans still stop at the moment a prescription is written. The prescribing moment gets the investment dollars, while adoption and adherence are left to a CRM email. That overlooks a key opportunity to support patients when they need it most.
Win treatment initiation and persistence in the post-prescription window
PSE uses Phreesia’s platform to meet patients in the moment right after a prescription is written or a treatment is ordered, when they likely have questions and follow through is uncertain. It’s a narrow window, but it’s where drop off happens. Timely support can make the biggest difference.
Why PSE?
Connected to a
trusted provider
Built into prescribing for pharmacy-filled and HCP-administered therapies
Supports
custom content
Curated to program segmentation with unique messaging capabilities
Demonstrates high
engagement
Delivers measurable performance metrics tied to program impact
The opportunity most brands haven’t seen yet
Most pharma marketers who prioritize adherence have yet to explore our PSE offering. Brands that recognize the post-prescription engagement moment and bridge the gap between when a prescription is written and filled can immediately:
- Extend their point-of-care investment to acquisition and beyond
- Reach newly prescribed patients with relevant content before drop off
- Generate adherence data that strengthens their outcomes story, including insights into reasons why patients hesitate to fill
What’s being said about PSE so far
For a product that’s still growing usage across our client base, the early results are clear. Those who’ve added it to their media mix are already seeing the solution deliver.
Extend your impact beyond the script
If medication uptake and adherence are priorities for your brand, PSE is the natural next step. It extends your PatientConnect investment deeper into the treatment journey while living on the same Phreesia platform with the compliance infrastructure you know and trust.
For more on how our PSE solution fills the adherence gap, download our infographic.
Talk to your Phreesia rep about adding PSE to your next campaign.
Based on Phreesia Network Solutions Client Feedback Survey, March 2026 (n=88).
